BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33610907)

  • 21. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
    Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
    Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
    Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
    Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
    Wen-Sheng W
    Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
    Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
    Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
    [No Abstract]   [Full Text] [Related]  

  • 26. C-terminus of PIEZO1 governs Ca
    Sugimoto A; Iwata K; Kurogoushi R; Tanaka M; Nakashima Y; Yamakawa Y; Oishi A; Yoshizaki K; Fukumoto S; Yamamoto A; Ishimaru N; Iwamoto T
    Biochem Biophys Res Commun; 2023 Nov; 682():39-45. PubMed ID: 37801988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
    Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
    Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
    Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
    Thomann S; Weiler SME; Marquard S; Rose F; Ball CR; Tóth M; Wei T; Sticht C; Fritzsche S; Roessler S; De La Torre C; Ryschich E; Ermakova O; Mogler C; Kazdal D; Gretz N; Glimm H; Rempel E; Schirmacher P; Breuhahn K
    Cancer Res; 2020 Dec; 80(24):5502-5514. PubMed ID: 33087321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
    Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
    J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
    Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
    PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calf Spleen Extractive Injection (CSEI), a small peptides enriched extraction, induces human hepatocellular carcinoma cell apoptosis via ROS/MAPKs dependent mitochondrial pathway.
    Jia D; Lu W; Zhang X; Cai G; Teng L; Wang X; Zhang M; Zeng Y; Liang C; Wang D
    J Pharmacol Sci; 2016 Oct; 132(2):122-130. PubMed ID: 28314430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.
    Song MK; Kim YJ; Song M; Choi HS; Park YK; Ryu JC
    Cancer Sci; 2011 Sep; 102(9):1636-44. PubMed ID: 21635667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective Chemical Activation of Piezo1 in Leukemia Cell Membrane: Single Channel Analysis.
    Vasileva V; Morachevskaya E; Sudarikova A; Negulyaev Y; Chubinskiy-Nadezhdin V
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
    Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous knockdown of YAP and TAZ increases apoptosis of hepatocellular carcinoma cells under hypoxic condition.
    Yan B; Li T; Shen L; Zhou Z; Liu X; Wang X; Sun X
    Biochem Biophys Res Commun; 2019 Jul; 515(2):275-281. PubMed ID: 31146919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
    Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J; Luo Z; Yao T; Li W; Pu J
    J Cell Physiol; 2019 May; 234(5):6908-6916. PubMed ID: 30317590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.